Lisa Kuhns, PhD, MD

News
Adjuvant Chemotherapy Significantly Boosts Survival in Upper Tract Urothelial Cancer
09/10/2024
Adjuvant chemotherapy significantly improves disease-free survival (DFS) for patients with muscle-invasive upper tract urothelial cancer (UTUC), according to study results published in the Journal of Clinical Oncology.
Adjuvant chemotherapy significantly improves disease-free survival (DFS) for patients with muscle-invasive upper tract urothelial cancer (UTUC), according to study results published in the Journal of Clinical Oncology.
Adjuvant chemotherapy...
09/10/2024
Veterans Health Today
News
Obesity and Age Identified as Key Risk Factors for SARS-CoV-2 Transmission
09/10/2024
Obesity significantly increases the risk of contracting COVID-19 upon exposure to the virus, with a 34% higher odds of testing positive compared to non-obese individuals, according to a study published in PNAS Nexus.
Obesity significantly increases the risk of contracting COVID-19 upon exposure to the virus, with a 34% higher odds of testing positive compared to non-obese individuals, according to a study published in PNAS Nexus.
Obesity significantly increases...
09/10/2024
Integrated Healthcare Executive
News
Challenges and Emerging Strategies in Overcoming Resistance in EGFR-Mutant NSCLC
09/10/2024
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...
Despite promising early results,...
09/10/2024
First Report Managed Care
News
New 4F-PCC Proves Effective in Rapid Reversal of Anticoagulation for Urgent Surgery, Clinical Trial Finds
09/10/2024
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...
An investigational 4-factor...
09/10/2024
First Report Managed Care
News
Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally...
09/03/2024
First Report Managed Care
News
Stereotactic Magnetic Resonance (MR)-Guided Radiotherapy Shows Promise for Inoperable Upper Tract Urothelial Carcinoma
09/03/2024
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided...
09/03/2024
First Report Managed Care
News
Targeting Expanded Follicular Regulatory T Cells Is a New Approach to Combat Follicular Lymphoma
08/26/2024
Follicular regulatory T cells (Tfr) are a potential target in treating follicular lymphoma (FL), the most common indolent B-cell lymphoma, according to study results published in Frontiers in Immunology.
Follicular regulatory T cells (Tfr) are a potential target in treating follicular lymphoma (FL), the most common indolent B-cell lymphoma, according to study results published in Frontiers in Immunology.
Follicular regulatory T cells...
08/26/2024
First Report Managed Care
News
Study Finds Gemcitabine-Docetaxel Combo Outperforms BCG in Treating High-Risk Bladder Cancer
08/23/2024
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel...
08/23/2024
First Report Managed Care
News
Study Finds Low Vaccination Rates Among Pregnant Women With HIV
08/23/2024
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for routine prenatal care, pregnant women living with HIV (PLHIV) are receiving routine vaccinations at alarmingly low rates, according to a study published in JAMA Network Open.
Despite recommendations for...
08/23/2024
First Report Managed Care
News
Targeting CD38 May Enhance Chemotherapy Efficacy in Small Cell Lung Cancer
08/21/2024
Targeting CD38 may significantly enhance the efficacy of chemotherapy in patients with small cell lung cancer (SCLC), according to study results published in Frontiers in Immunology.
Targeting CD38 may significantly enhance the efficacy of chemotherapy in patients with small cell lung cancer (SCLC), according to study results published in Frontiers in Immunology.
Targeting CD38 may significantly...
08/21/2024
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use